Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sepranolone in Women With Menstrual Migraine
NCT04102995Phase 2Completed
- Sponsor
- Asarina Pharma AB
- Start
- Aug 2019
- Primary completion
- May 2021
- Modality
- Allosteric Modulators
- Countries
- 2
01
Overview
A Phase 2 trial of sepranolone in menstrual migraine, sponsored by Asarina Pharma AB. Started Aug 2019; status: completed.
02
Drugs
sepranolone
03
Conditions
menstrual migraine
Beyond the preview
Go deeper on NCT04102995.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04102995.